- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- News News
- Join Join
When the United Nations General Assembly Special Session (UNGASS) convenes in New York next Tuesday, delegates will be discussing global drug policy – including what to do about medical cannabis. This is a historic meeting, and the ramifications for national and international medical cannabis policy could be huge.
ASA would like to provide every delegate from the 180 nations represented with a groundbreaking report we prepared this year for the UN Commission on Narcotic Drugs. The 91-page report, which was peer-reviewed at our annual conference in March, answers important scientific questions about medical cannabis, and outlines a pathway towards international reform.
Pictured: ASA Executive Director Steph Sherer and an international delegation from France, the Czech Republic, the Netherlands, and Jamaica delivering the report to the UNCND in March.
This report matters for patients and researchers in the United States and elsewhere, because the UN Single Convention Treaty on Narcotics of 1961 is an obstacle for medical cannabis reform worldwide. We need the UN to change its policies, but the last comprehensive UN report on cannabis was published in 1935.
Delegates at UNGASS need the up-to-date information in our report to make recommendations based on modern science. They need to have better information to make better choices about medical cannabis.
This could be a global turning point for medical cannabis. But if we do not take this information directly to the delegates, there is no guarantee they will see it.
We are closer than ever to realizing our goal of safe and legal access to medical cannabis for everyone who needs it. Thank you for helping us take this important next step.
By the way... You can mail a check or money order to Americans for Safe Access at 1624 U Street NW, Suite 200, Washington, DC 20009.